AmerisourceBergen (NYSE:ABC) and two large rivals effectively control the market for distributing drugs from drug manufacturers to drug retailers, hospitals and similar locations where consumers go to fill their prescriptions. The industry has grown steadily for more than a decade now, but is showing little sign of slowing down.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

Recent Developments
At a healthcare conference earlier this year, Amerisource provided an overview of its business and expectations for growth. Industry growth has been solid, as the need to distribute drugs increases, along with an aging population. The expiration of patents on blockbuster drugs also favors the distribution players, as they are able to garner higher profit margins.

Over the past decade, this has roughly translated into 19% annual profit growth for Amerisource. It sees great potential for the coming decade, with demographics of older Americans supporting organic growth and the expansion of healthcare coverage overall, meaning more overall patients. Management sees closer links between the distributors and drug manufacturers over time, which it plans to combine with internal "cost containment efforts" to continue to grow profits in the double digits.

SEE: Healthcare Funds: Give Your Portfolio A Booster Shot

Outlook and Valuation
Amerisource has long-term financial goals to grow the top line at industry rates but leverage that into annual earnings above 15%. This is expected to come from cost cutting and distribution efficiencies, which management expects to translate into operating margin expansion over time. Free cash flow should continue to come in at about reported net income, and it plans to return at least 30% of free cash flow generated to shareholders. This will stem from dividend payouts and share buybacks.

For the full year, analysts currently project sales growth of 1.2%, total sales just over $81 billion, and earnings of $2.82 per share or annual growth of around 10%. This represents a forward earnings multiple of just below 13.

SEE: Investing In The Healthcare Sector

The Bottom Line
Amerisource's archrivals include McKesson (NYSE:MCK) and Cardinal Health (NYSE:CAH). All are currently trading at forward P/Es in the low double-digits. All three generally perform the same function of distributing drugs but differ somewhat in their geographic mix and clients served. Henry Schein (Nasdaq:HSIC) and Express Scripts (Nasdaq:ESRX) also serve as rivals.

SEE: Where Can Americans Go For Cheaper Healthcare

Express Scripts recently merged with Medco Health Solutions to form the largest pharmacy benefit management firm. Last year, Medco was Amerisource's largest customer at 19% of the top line. According to a company filing, its contract with Medco runs through March 2013, but appears to be stable as there are few alternative options out there. Overall, the industry has great growth prospects and the leading players are trading at very reasonable earnings valuations given the expansion expectations.

At the time of writing, Ryan C. Fuhrmann did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  2. Investing

    How to Win More by Losing Less in Today’s Markets

    The further you fall, the harder it is to climb back up. It’s a universal truth that is painfully apparent in the investing world.
  3. Investing

    5 Recession Resistant Industries

    No companies are completely recession proof, but some industries perform better in a weak economy than others.
  4. Fundamental Analysis

    Use Options Data To Predict Stock Market Direction

    Options market trading data can provide important insights about the direction of stocks and the overall market. Here’s how to track it.
  5. Stock Analysis

    2 Oil Stocks to Buy Right Now (PSX,TSO)

    Can these two oil stocks buck the trend?
  6. Investing News

    What Alcoa’s (AA) Breakup Means for Investors

    Alcoa plans to split into two companies. Is this a bullish catalyst for investors?
  7. Investing

    A Look at 6 Leading Female Value Investors

    In an industry still largely predominated by men, we look at 6 leading female value investors working today.
  8. Term

    What Is Financial Performance?

    Financial performance measures a firm’s ability to generate profits through the use of its assets.
  9. Stock Analysis

    Top 3 Stocks for the Coming Holiday Season

    If you want to buck the bear market trend by going long on consumer stocks, these three might be your best bets.
  10. Investing News

    Could a Rate Hike Send Stocks Higher?

    A rate hike would certainly alter the investment scene, but would it be for the better or worse?
  1. How do I use discounted cash flow (DCF) to value stock?

    Discounted cash flow (DCF) analysis can be a very helpful tool for analysts and investors in equity valuation. It provides ... Read Full Answer >>
  2. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  3. What is the formula for calculating compound annual growth rate (CAGR) in Excel?

    The compound annual growth rate, or CAGR for short, measures the return on an investment over a certain period of time. Below ... Read Full Answer >>
  4. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  5. When does the fixed charge coverage ratio suggest that a company should stop borrowing ...

    Since the fixed charge coverage ratio indicates the number of times a company is capable of making its fixed charge payments ... Read Full Answer >>
  6. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!